Buck, A. et al. Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients. J. Pathol. 256, 202-213 (2022)
Lansink Rotgerink, L.* et al. Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapy. J. Pathol. 258, 189-198 (2022)
Alston, C.L.* ; Stenton, S. ; Hudson, G.* ; Prokisch, H. & Taylor, R.W.* The genetics of mitochondrial disease: Dissecting mitochondrial pathology using multi-omic pipelines. J. Pathol. 254, 430-442 (2021)
Ganz, H.M. et al. Generation of ductal organoids from normal mammary luminal cells reveals invasive potential. J. Pathol., DOI: 10.1002/path.5790 (2021)
Vockerodt, M.* et al. Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma. J. Pathol. 248, 142-154 (2019)
Fichter, C.D.* et al. A new model system identifies EGFR/HER2 and HER2/HER3 heterodimers as potent inducers of oesophageal epithelial cell invasion. J. Pathol. 243, 481-495 (2017)
Buck, A. et al. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed paraffin-embedded clinical tissue samples. J. Pathol. 237, 123–132 (2015)
Ringelhan, M. ; Protzer, U. ; O'Connor, T.* & Heikenwälder, M. The direct and indirect role of HBV in liver cancer: Prospective markers for HCC-screening and potential therapeutic targets. J. Pathol. 235, 355-367 (2015)
Aichler, M. & Walch, A.K. In brief: The (molecular) pathogenesis of Barrett's oesophagus. J. Pathol. 232, 383-385 (2014)
Balluff, B.* et al. De novo discovery of phenotypic intra-tumor heterogeneity using imaging mass spectrometry. J. Pathol. 235, 3-13 (2014)
Aichler, M. et al. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J. Pathol. 230, 410-419 (2013)
Richter, G.H.S.* et al. G-protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1. J. Pathol. 230, 70-81 (2013)
Aichler, M. et al. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: A comparative study in transgenic mice and human tissues. J. Pathol. 226, 723-734 (2012)
Meding, S. et al. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J. Pathol. 228, 459-470 (2012)
Wolff, C.* et al. Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: New insights from protein microarray analysis. J. Pathol. 223, 54-63 (2011)
Warren, M.V.* et al. An impending crisis in the provision of histopathology expertise for mouse functional genomics. J. Pathol. 217, 4-13 (2009)
Becker, K.-F.* et al. Quantitative protein analysis from formalin-fixed tissues: Implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 211, 370-378 (2007)
Gerlach, U.* et al. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. J. Pathol. 208, 462-472 (2006)
Hennard, C. et al. The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen I (EBNA I) detects MAGE-4: Implications for studies on the EBV association of human cancers. J. Pathol. 209, 430-435 (2006)
Schreck, S.* et al. Activation-induced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J. Pathol. 210, 26-31 (2006)
Born, M. et al. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J. Pathol. 205, 592-596 (2005)
Greiner, A.* et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J. Pathol. 205, 541-547 (2005)
Kremer, M.* et al. Primary extramedullary plasmacytoma and multiple myeloma: Phenotypic differences revealed by immunohistochemical analysis. J. Pathol. 205, 92-101 (2005)
Albrecht, B.* et al. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J. Pathol. 203, 780-788 (2004)
Heussinger, N.* et al. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J. Pathol. 203, 696-699 (2004)
Kammerer, R.* et al. The tumour suppressor gene CEACAMI is completely but reversibly downregulated in renal cell carcinoma. J. Pathol. 204, 258-267 (2004)
Kappler, R.* et al. Molecular characterization of Patched-associated rhabdomyosarcoma. J. Pathol. 200, 348-356 (2003)
Becker, K.-F. et al. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies. J. Pathol. 197, 567-574 (2002)
Gerber, J.-K. et al. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J. Pathol. 197, 293-297 (2002)
Huss, R.* et al. In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62dok protein. J. Pathol. 192, 363-372 (2000)
Zitzelsberger, H. et al. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J. Pathol. 172, 325-335 (1994)